Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
The onset of insulin resistance, the sites of action, and the mechanisms through which tumor necrosis factor-alpha (TNF-alpha) exacerbates the increase in adiposity and the development of insulin resistance in mice fed high-fat (HF) diet remain unclear. Here we investigated the effect of TNF-alpha deficiency on adiposity and insulin resistance during the initial 1 to 4 weeks of HF feeding. We examined body weight; the distribution of white adipose tissue (WAT); homeostasis model assessment; and levels of leptin, resistin, and adiponectin in the initial 4 weeks of HF feeding in TNF-alpha knockout (KO) mice and wild-type (WT) controls. Through 4 weeks of HF feeding, KO mice, unlike WT mice, maintained normal insulin sensitivity. Although WT-HF and KO-HF mice had similar levels of WAT at this time, KO-HF mice had more subcutaneous and less epididymal fat than WT-HF mice. The KO-HF mice also had less liver fat than the WT-HF mice. Finally, KO-HF mice had lower plasma levels of resistin than WT-HF mice. These data demonstrate that genetic lack of TNF-alpha protects insulin sensitivity during the early phase of HF feeding in the absence of altered total WAT. The data also suggest that the mechanism maintaining insulin sensitivity in the absence of TNF-alpha may involve redirection of the fat deposition to the metabolically more inert subcutaneous depot or decreases in circulating resistin and resultant decrease in liver fat deposition. The efficacy of therapeutic measures designed to counteract the effects of TNF-alpha may be increased during the early stages of obesity and insulin resistance.
Bouter
Brenda
B
Institute of Food, Nutrition and Health, Physiology and Behavior Group, ETH-Zürich, Schwerzenbach, Switzerland.
Geary
Nori
N
Langhans
Wolfgang
W
Asarian
Lori
L
D052242:Adiponectin / Q000097:blood; D050154:Adiposity / Q000235:genetics; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000235:genetics / Q000502:physiology; D004032:Diet; D005234:Fatty Liver / Q000235:genetics / Q000378:metabolism; D005838:Genotype; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics* / Q000502:physiology*; D020738:Leptin / Q000097:blood; D050356:Lipid Metabolism / Q000235:genetics / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009765:Obesity / Q000235:genetics* / Q000378:metabolism*; D052243:Resistin / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics* / Q000502:physiology*
D052242:Adiponectin; D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D052243:Resistin; D014409:Tumor Necrosis Factor-alpha